Lumosa Therapeutics (6535) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 順藥

Lumosa Therapeutics (6535) reported revenue of NT$78,000 for Oct 2026, -54.9% year on year and -63.0% from the previous month. Revenue for Jan–Oct 2026 was NT$19 million (-17.1% year on year).

In Oct 2026, it ranked No. 152 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$40,00024/10Nov 2024 NT$4.2 millionDec 2024 NT$17.3 millionJan 2025 NT$40,000Feb 2025 NT$40,00025/02Mar 2025 NT$8.8 millionApr 2025 NT$469,000May 2025 NT$220,000Jun 2025 NT$1.5 million25/06Jul 2025 NT$7.3 millionAug 2025 NT$173,000Sep 2025 NT$4.3 millionOct 2025 NT$173,00025/10Nov 2025 NT$173,000Dec 2025 NT$14 millionJan 2026 NT$4 millionFeb 2026 NT$30,00026/02Mar 2026 NT$503,000Apr 2026 NT$78,000May 2026 NT$78,000Jun 2026 NT$5 million26/06Jul 2026 NT$78,000Aug 2026 NT$9.1 millionSep 2026 NT$211,000Oct 2026 NT$78,00026/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$78,000-54.9%-63.0%
Sep 2026NT$211,000-95.1%-97.7%
Aug 2026NT$9.1 million+5,135.8%+11,512.8%
Jul 2026NT$78,000-98.9%-98.4%
Jun 2026NT$5 million+233.5%+6,275.6%
May 2026NT$78,000-64.5%+0.0%
Apr 2026NT$78,000-83.4%-84.5%
Mar 2026NT$503,000-94.3%+1,576.7%
Feb 2026NT$30,000-25.0%-99.2%
Jan 2026NT$4 million+9,777.5%-71.7%
Dec 2025NT$14 million-19.3%+7,971.7%
Nov 2025NT$173,000-95.8%+0.0%
Oct 2025NT$173,000+332.5%-95.9%
Sep 2025NT$4.3 million+1,056.9%+2,367.6%
Aug 2025NT$173,000+332.5%-97.6%
Jul 2025NT$7.3 million+21.8%+387.1%
Jun 2025NT$1.5 million+297.6%+577.7%
May 2025NT$220,000-94.9%-53.1%
Apr 2025NT$469,000-87.9%-94.7%
Mar 2025NT$8.8 million+2,250.9%+21,940.0%
Feb 2025NT$40,000+0.0%+0.0%
Jan 2025NT$40,000-99.0%-99.8%
Dec 2024NT$17.3 million+93.1%+315.2%
Nov 2024NT$4.2 million-59.4%+10,317.5%
Oct 2024NT$40,000+0.0%-89.2%

Jan–Oct 2026 cumulative: NT$19 million (-17.1% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Lumosa Therapeutics vs PEC / Lumosa Therapeutics vs Lotus Pharm / Lumosa Therapeutics vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

Company remark (original Chinese)

本月勞務收入較去年同期減少

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16